RecruitingNCT06587828
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
Studying Birdshot chorioretinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- TScan Therapeutics, Inc.
- Intervention
- Companion blood samples with procedure(procedure)
- Enrollment
- 300 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (11)
- Knowledge Research Center, Orange, California, United States
- Cura Clinical Research, Sherman Oaks, California, United States
- Arnold Arthritis & Rheumatology, Skokie, Illinois, United States
- University of Kentucky Research Foundation, Lexington, Kentucky, United States
- Massachusetts Eye Research and Surgery Institution (MERSI), Waltham, Massachusetts, United States
- Susquehanna Research Group, Harrisburg, Pennsylvania, United States
- Nexus Research, Cranston, Rhode Island, United States
- RI Rheumatology, Cranston, Rhode Island, United States
- Palmetto Gastroenterology Clinical Research, LLC, Summerville, South Carolina, United States
- Novel Research, Bellaire, Texas, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06587828 on ClinicalTrials.govOther trials for Birdshot chorioretinopathy
Additional recruiting or active studies for the same condition.